Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  The Role of Retinal G Protein-Coupled Receptor in Age-Related Macular Degeneration


   School of Medicine, Medical Sciences & Nutrition

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Dr I J Crane, Dr Fiona Murray  No more applications being accepted  Competition Funded PhD Project (European/UK Students Only)

About the Project

Supervisors: Dr Isabel Crane and Dr Fiona Murray

Age-related macular degeneration (AMD) is the leading cause of blindness in the industrialised world affecting 5% of those over 70 with no effective treatment for the disease. AMD is characterised by an early, progressive degeneration of retinal pigment epithelial cells (RPE), which leads to photoreceptor death. G protein-coupled receptors are a family of cell-surface receptors, which regulate a vast array of physiological processes and are the target for a number of drugs. One GPCR, namely the retinal GPCR, is highly expressed in RPEs and has been implicated in the genetic susceptibility to AMD. This project aims to uncover the role of retinal GPCR and its variants in RPE function and determine its role in the progression of AMD. Primary human RPE cell lines and HEK293 cells, which will be transfected with retinal GPCR, will be used to investigate its role in RPE survival and to dissect the signalling pathways it mediates. Screens will be developed to identify novel ligands for retinal GPCR. Uncovering the role of retinal GPCR has the potential to generate translation research by identifying a novel target or biomarker for AMD. The student will gain training in various cell biology, molecular biology and biochemical techniques.

Funding Notes

This project is part of a competition funded by the Institute of Medical Sciences. Full funding is available to UK/EU applicants only. International candidates are welcome to apply but may need to provide their own funding of approximately £12,000 per annum to meet the difference between UK and Overseas fees.

Candidates should have (or expect to achieve) a minimum of a 2.1 Honours degree in a relevant subject. Applicants with a minimum of a 2.2 Honours degree may be considered provided they have a Distinction at Masters level.

References

Ambati J et al. Nat Rev Immunol. 2013;13:438-51.

Tarttelin EE et al. BBRC 1999;260:174-80.

Ignatov A et al. Br J Pharm. 2006;149:490-7.

Insel PA et al. Br J Pharmacol 2012;165:1613-6.

Where will I study?